{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:11:45Z","timestamp":1790734305556,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ophtha.2006.12.011","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T07:24:06Z","timestamp":1188977046000},"page":"1622-1629","source":"Crossref","is-referenced-by-count":100,"title":["Clinical Efficacy of Moxifloxacin in the Treatment of Bacterial Keratitis"],"prefix":"10.1016","volume":"114","author":[{"given":"Marios","family":"Constantinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daniell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Snibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien T.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.12.011_bib1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bjo.87.9.1169","article-title":"Microbial keratitis: what\u2019s the preferred initial therapy?","volume":"87","author":"Morlet","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archopht.1982.01030030079005","article-title":"Ulcerative keratitis: survey of 30 years\u2019 laboratory experience","volume":"100","author":"Asbell","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib3","series-title":"Infectious Diseases","first-page":"1355","article-title":"Infections of the eye","author":"Baum","year":"1998"},{"key":"10.1016\/j.ophtha.2006.12.011_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bjo.71.2.96","article-title":"Host, microbial and pharmacological factors affecting the outcome of suppurative keratitis","volume":"71","author":"Coster","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0039-6257(79)90128-0","article-title":"Initial therapy of suspected microbial corneal ulcers. II","volume":"24","author":"Jones","year":"1979","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib6","series-title":"Principles and Practice of Infectious Diseases","first-page":"981","article-title":"Keratitis","author":"McDonnell","year":"1990"},{"key":"10.1016\/j.ophtha.2006.12.011_bib7","series-title":"Infectious Diseases: A Modern Treatise of Infectious Processes","first-page":"1443","article-title":"Corneal infections","author":"Ostler","year":"1989"},{"key":"10.1016\/j.ophtha.2006.12.011_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0039-6257(79)90127-9","article-title":"Initial therapy of suspected microbial corneal ulcers. I","volume":"24","author":"Baum","year":"1979","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archopht.1989.01070020352011","article-title":"Aminoglycoside macular toxicity after subconjunctival injection: case report","volume":"167","author":"Judson","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1993.01090090062020","article-title":"0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis","volume":"111","author":"Wilhelmus","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archopht.1995.01100100045026","article-title":"Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the Bacterial Keratitis Study Research Group","volume":"113","author":"O\u2019Brien","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib12","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0161-6420(97)30009-8","article-title":"Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy","volume":"104","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.011_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","article-title":"Ciprofloxacin-resistant Pseudomonas keratitis","volume":"106","author":"Garg","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.011_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0161-6420(99)00716-2","article-title":"Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review","volume":"106","author":"Goldstein","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.011_bib15","first-page":"153","article-title":"Polymicrobial keratitis","volume":"79","author":"Jones","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2006.12.011_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archopht.1972.01000030555018","article-title":"Cornea and sclera","volume":"88","author":"Laibson","year":"1972","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9394(14)75075-5","article-title":"Spectrum of microbial keratitis in South Florida","volume":"90","author":"Liesegang","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM197807062990107","article-title":"Current concepts in ophthalmology: ocular infections","volume":"299","author":"Baum","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.12.011_bib19","first-page":"541","article-title":"Experimental Pseudomonas keratitis","volume":"79","author":"Hyndiuk","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2006.12.011_bib20","first-page":"21","article-title":"Pseudomonas keratitis following cosmetic soft contact lens wear","volume":"10","author":"Freedman","year":"1976","journal-title":"Contact Lens J"},{"key":"10.1016\/j.ophtha.2006.12.011_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0002-9394(81)90649-8","article-title":"Pseudomonas corneal ulcers associated with soft contact-lens wear","volume":"82","author":"Wilson","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archopht.1983.01040020547007","article-title":"Demographic and predisposing factors in corneal ulceration","volume":"101","author":"Musch","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers","volume":"103","author":"Hyndiuk","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.011_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-9394(85)90364-2","article-title":"Loading doses and extended dosing intervals in topical gentamycin therapy","volume":"99","author":"Glasser","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib25","first-page":"46","article-title":"Toxic effects of antimicrobials on the ocular surface of healthy volunteers","volume":"8","author":"Rolando","year":"1991","journal-title":"Chibret Int J Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ophtha.2006.12.011_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/43.suppl_2.1","article-title":"A review of the comparative in vitro activities of 12 antimicrobial agents, with a focus on five new \u201crespiratory quinolones.\u201d","volume":"43","author":"Blondeau","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ophtha.2006.12.011_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239474","article-title":"In vitro activity of Bay 12 8039, a new 8 methoxyquinolone","volume":"42","author":"Dalhoff","year":"1996","journal-title":"Chemotherapy"},{"issue":"suppl","key":"10.1016\/j.ophtha.2006.12.011_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/43.suppl_2.19","article-title":"In-vitro activity of moxifloxacin against fluoroquinolone resistant strains of aerobic Gram negative bacilli and Enterococcus faecolis","volume":"43","author":"Tankovic","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ophtha.2006.12.011_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s100960050284","article-title":"Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests","volume":"18","author":"Barry","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"suppl","key":"10.1016\/j.ophtha.2006.12.011_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/43.suppl_2.31","article-title":"The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus","volume":"43","author":"Schedletzky","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ophtha.2006.12.011_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(00)00642-5","article-title":"Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis","volume":"131","author":"Mallari","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.011_bib34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.12.011_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin and ofloxacin using bacterial keratitis isolates","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.12.011_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bjo.84.4.378","article-title":"Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers","volume":"84","author":"Gangopadhyay","year":"2000","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006016149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006016149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T14:23:11Z","timestamp":1546611791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642006016149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0161642006016149"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.12.011","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}